[Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia]
- PMID: 9216213
[Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia]
Abstract
KL-6 is a high-molecular-weight glycoprotein that is classified in cluster 9 among pulmonary cell antigens. Levels of KL-6 were found to be abnormally high in sera from patients with various types of interstitial pneumonitis such as idiopathic interstitial pneumonia, which can progress to pulmonary fibrosis. Levels of KL-6 in serum can be useful serum markers in the diagnosis of idiopathic interstitial pneumonia, in monitoring in the evaluation of disease activity, as a prognostic factor, and as a predictor of response to therapy.
Similar articles
-
Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.J Med Invest. 1999 Aug;46(3-4):151-8. J Med Invest. 1999. PMID: 10687309 Review.
-
[Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Jun;34(6):639-45. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 8741528 Clinical Trial. Japanese.
-
[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].Ryumachi. 2003 Feb;43(1):19-28. Ryumachi. 2003. PMID: 12692986 Japanese.
-
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].Rinsho Byori. 2000 Jun;48(6):554-60. Rinsho Byori. 2000. PMID: 10897675 Clinical Trial. Japanese.
-
[Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].Nihon Naika Gakkai Zasshi. 2003 Oct 10;92(10):1985-9. Nihon Naika Gakkai Zasshi. 2003. PMID: 14621589 Review. Japanese. No abstract available.
Cited by
-
CA 15 - 3 in screening for systemic autoimmune rheumatic disease associated interstitial lung disease: a single center cross-sectional study.Rheumatol Int. 2024 Oct;44(10):2017-2025. doi: 10.1007/s00296-024-05694-2. Epub 2024 Aug 24. Rheumatol Int. 2024. PMID: 39180532
-
Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.World J Gastroenterol. 2014 Sep 14;20(34):12171-81. doi: 10.3748/wjg.v20.i34.12171. World J Gastroenterol. 2014. PMID: 25232251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous